Triggers and drivers of autoimmunity: Lessons from coeliac disease

Nature Reviews Immunology

Volumn 13, Issue 4, 2013, Pages 294-302

  Sollid, Ludvig M ^a   Jabri, Bana ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CITRULLINE PROTEIN ANTIBODY; DEOXYRIBONUCLEASE I; GLUTEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DQB1 ANTIGEN; INTERFERON; INTERLEUKIN 15; INTERLEUKIN 21; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CELL INFILTRATION; CYTOTOXIC T LYMPHOCYTE; HUMAN; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELIAC DISEASE; GLUTENS; HUMANS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 84875410166     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3407     Document Type: Review

References (113)

1. Dicke, W. Coeliac disease. Investigation of the harmful effects of certain types of cereal on patients with coeliac disease. Thesis, Univ. Utrecht (1950).
2. van Berge-Henegouwen, G. P. & Mulder, C. J. Pioneer in the gluten free diet: Willem-Karel Dicke 1905-1962, over 50 years of gluten free diet. Gut 34, 1473-1475 (1993). (Pubitemid 23341829)
3. Paulley, J. W. Observation on the aetiology of idiopathic steatorrhoea; jejunal and lymph-node biopsies. Br. Med. J. 2, 1318-1321 (1954).
4. Green, P. H. & Cellier, C. Celiac disease. N. Engl. J. Med. 357, 1731-1743 (2007).
5. Dieterich, W. et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med. 3, 797-801 (1997). (Pubitemid 27298728)
6. Sollid, L. M. & Lie, B. A. Celiac disease genetics: current concepts and practical applications. Clin. Gastroenterol. Hepatol. 3, 843-851 (2005). (Pubitemid 41222309)
7. Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nature Genet. 43, 1193-1201 (2011).
8. Smyth, D. J. et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 359, 2767-2777 (2008).
9. Zhernakova, A. et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet. 7, e1002004 (2011).
10. Trynka, G., Wijmenga, C. & van Heel, D. A. A genetic perspective on coeliac disease. Trends Mol. Med. 16, 537-550 (2010).
11. Cotsapas, C. et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 7, e1002254 (2011).
12. Voight, B. F. & Cotsapas, C. Human genetics offers an emerging picture of common pathways and mechanisms in autoimmunity. Curr. Opin. Immunol. 24, 552-557 (2012).
13. Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190-1195 (2012).
14. Lyons, P. A. et al. Genetically distinct subsets within ANCA-associated vasculitis. N. Engl. J. Med. 367, 214-223 (2012).
15. van Venrooij, W. J., van Beers, J. J. & Pruijn, G. J. Anti-CCP antibodies: the past, the present and the future. Nature Rev. Rheumatol. 7, 391-398 (2011).
16. Marzari, R. et al. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J. Immunol. 166, 4170-4176 (2001). (Pubitemid 32224950)
17. Di Niro, R. et al. High abundance of plasma cells secreting transglutaminase 2specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nature Med. 18, 441-445 (2012).
18. Bjorck, S., Brundin, C., Lorinc, E., Lynch, K. F. & Agardh, D. Screening detects a high proportion of celiac disease in young HLA-genotyped children. J. Pediatr. Gastroenterol. Nutr. 50, 49-53 (2010).
19. Klareskog, L., Ronnelid, J., Lundberg, K., Padyukov, L. & Alfredsson, L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26, 651-675 (2008). (Pubitemid 351600388)
20. Sollid, L. M. Molecular basis of celiac disease. Annu. Rev. Immunol. 18, 53-81 (2000). (Pubitemid 30365374)
21. Turner, J. R. in Robbins and Cotran Pathologic Basis of Disease (eds Kumar, V., Abbas, A. K., Fausto, N. & Aster, J. C.) 763-831 (Elsevier, 2009).
22. Hüe, S. et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21, 367-377 (2004). (Pubitemid 39208338)
23. Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357-366 (2004). (Pubitemid 39208337)
24. Meresse, B. et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203, 1343-1355 (2006). (Pubitemid 43736602)
25. Jabri, B. & Sollid, L. M. Tissue-mediated control of immunopathology in coeliac disease. Nature Rev. Immunol. 9, 858-870 (2009).
26. Groh, V., Bruhl, A., ElGabalawy, H., Nelson, J. L. & Spies, T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 100, 9452-9457 (2003). (Pubitemid 37033949)
27. Ogasawara, K. et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20, 757-767 (2004). (Pubitemid 38757445)
28. Asquith, D. L. & McInnes, I. B. Emerging cytokine targets in rheumatoid arthritis. Curr. Opin. Rheumatol. 19, 246-251 (2007). (Pubitemid 46597461)
29. Michalak-Stoma, A. et al. Cytokine network in psoriasis revisited. Eur. Cytokine Netw. 22, 160-168 (2011).
30. Rentzos, M. & Rombos, A. The role of IL15 in central nervous system disorders. Acta Neurol. Scand. 125, 77-82 (2012).
31. Mention, J. J. et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125, 730-745 (2003).
32. Tang, F. et al. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL15. J. Exp. Med. 206, 707-719 (2009).
33. Groh, V. et al. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nature Immunol. 2, 255-260 (2001). (Pubitemid 33706003)
34. Roberts, A. I. et al. NKG2D receptors induced by IL15 costimulate CD28negative effector CTL in the tissue microenvironment. J. Immunol. 167, 5527-5530 (2001). (Pubitemid 33062738)
35. Sulkanen, S. et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115, 1322-1328 (1998). (Pubitemid 28545980)
36. Bardella, M. T. et al. Coeliac disease: a histological followup study. Histopathology 50, 465-471 (2007). (Pubitemid 46328182)
37. Molberg, O. et al. Gliadin specific, HLA DQ2restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand. J. Immunol. 46, 103-108 (1997). (Pubitemid 27298870)
38. Sollid, L. M., Qiao, S. W., Anderson, R. P., Gianfrani, C. & Koning, F. Nomenclature and listing of celiac disease relevant gluten Tcell epitopes restricted by HLADQ molecules. Immunogenetics 64, 455-460 (2012).
39. Lundin, K. E. et al. Gliadin-specific, HLADQ(α1&z.ast;0501, β1&z.ast;0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J. Exp. Med. 178, 187-196 (1993). (Pubitemid 23173254)
40. Lundin, K. E., Scott, H., Fausa, O., Thorsby, E. & Sollid, L. M. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum. Immunol. 41, 285-291 (1994).
41. Molberg, O. et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Med. 4, 713-717 (1998). (Pubitemid 28274673)
42. van de Wal, Y. et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol. 161, 1585-1588 (1998). (Pubitemid 28387571)
43. Tollefsen, S. et al. HLADQ2 and-DQ8 signatures of gluten T cell epitopes in celiac disease. J. Clin. Invest. 116, 2226-2236 (2006). (Pubitemid 44162332)
44. Osman, A. A. et al. B cell epitopes of gliadin. Clin. Exp. Immunol. 121, 248-254 (2000). (Pubitemid 30659761)
45. Shan, L. et al. Structural basis for gluten intolerance in celiac sprue. Science 297, 2275-2279 (2002).
46. Bodd, M. et al. HLADQ2restricted gluten-reactive T cells produce IL21 but not IL17 or IL22. Mucosal Immunol. 3, 594-601 (2010).
47. Abadie, V., Sollid, L. M., Barreiro, L. B. & Jabri, B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu. Rev. Immunol. 29, 493-525 (2011).
48. Sollid, L. M. Coeliac disease: dissecting a complex inflammatory disorder. Nature Rev. Immunol. 2, 647-655 (2002). (Pubitemid 37328722)
49. Mäki, M. in Seventh International Symposium on Coeliac Disease (eds Feighery, C. & O'Farelly, C.) 246-252 (Oak Tree Press, 1992).
50. Sollid, L. M., Molberg, O., McAdam, S. & Lundin, K. E. Autoantibodies in coeliac disease: tissue transglutaminase-guilt by association? Gut 41, 851-852 (1997). (Pubitemid 28023192)
51. Fleckenstein, B. et al. Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides. J. Biol. Chem. 279, 17607-17616 (2004). (Pubitemid 38560525)
52. Prause, C. et al. Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease. J. Pediatr. Gastroenterol. Nutr. 49, 52-58 (2009).
53. Devendra, D. & Eisenbarth, G. S. Interferon alpha-a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin. Immunol. 111, 225-233 (2004). (Pubitemid 38739316)
54. Fujinami, R. S. & Oldstone, M. B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230, 1043-1045 (1985). (Pubitemid 16192692)
55. Wucherpfennig, K. W. & Strominger, J. L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80, 695-705 (1995).
56. Lawson, C. M. Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cell. Mol. Life Sci. 57, 552-560 (2000). (Pubitemid 30311426)
57. Pabst, O. & Mowat, A. M. Oral tolerance to food protein. Mucosal Immunol. 5, 232-239 (2012).
58. DePaolo, R. W. et al. Coadjuvant effects of retinoic acid and IL15 induce inflammatory immunity to dietary antigens. Nature 471, 220-224 (2011).
59. Monteleone, G. et al. Role of interferon α in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 48, 425-429 (2001). (Pubitemid 32269575)
60. Raki, M. et al. Plasmacytoid dendritic cells are scarcely represented in the human gut mucosa and are not recruited to the celiac lesion. Mucosal Immunol. 23 Jan 2013 (doi:10.1038/mi.2012.136
61. Medzhitov, R. & Janeway, C. A. Jr. Innate immune recognition and control of adaptive immune responses. Semin. Immunol. 10, 351-353 (1998). (Pubitemid 28499548)
62. Di Sabatino, A. et al. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology 133, 1175-1187 (2007). (Pubitemid 47494463)
63. Maiuri, L. et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362, 30-37 (2003). (Pubitemid 36835817)
64. Barone, M. V. et al. Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut 56, 480-488 (2007). (Pubitemid 46580502)
65. Terrazzano, G. et al. Gliadin regulates the NK-dendritic cell cross-talk by HLAE surface stabilization. J. Immunol. 179, 372-381 (2007). (Pubitemid 46986554)
66. Junker, Y. et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J. Exp. Med. 209, 2395-2408 (2012).
67. Troncone, R. & Auricchio, S. Rotavirus and celiac disease: clues to the pathogenesis and perspectives on prevention. J. Pediatr. Gastroenterol. Nutr. 44, 527-528 (2007). (Pubitemid 46684352)
68. Stene, L. C. et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am. J. Gastroenterol. 101, 2333-2340 (2006). (Pubitemid 44477562)
69. Hober, D. & Sauter, P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nature Rev. Endocrinol. 6, 279-289 (2010).
70. Siegel, M. et al. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS ONE 3, e1861 (2008).
71. Jun, H. S. & Yoon, J. W. A new look at viruses in type 1 diabetes. Diabetes Metab. Res. Rev. 19, 8-31 (2003).
72. Rizza, P., Moretti, F. & Belardelli, F. Recent advances on the immunomodulatory effects of IFNα: implications for cancer immunotherapy and autoimmunity. Autoimmunity 43, 204-209 (2010).
73. Carrero, J. A., Calderon, B. & Unanue, E. R. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 200, 535-540 (2004). (Pubitemid 39121910)
74. Woodward, J. J., Iavarone, A. T. & Portnoy, D. A. cdiAMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 328, 1703-1705 (2010).
75. Manca, C. et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFNα/β. Proc. Natl Acad. Sci. USA 98, 5752-5757 (2001). (Pubitemid 32435714)
76. Jones, J. W. et al. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc. Natl Acad. Sci. USA 107, 9771-9776 (2010).
77. Round, J. L. & Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease. Nature Rev. Immunol. 9, 313-323 (2009).
78. Maynard, C. L., Elson, C. O., Hatton, R. D. & Weaver, C. T. Reciprocal interactions of the intestinal microbiota and immune system. Nature 489, 231-241 (2012).
79. Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions between the microbiota and the immune system. Science 336, 1268-1273 (2012).
80. Atkinson, M. A. & Chervonsky, A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia 55, 2868-2877 (2012).
81. Mathis, D. & Benoist, C. Microbiota and autoimmune disease: the hosted self. Cell Host Microbe 10, 297-301 (2011).
82. Forsberg, G. et al. Presence of bacteria and innate immunity of intestinal epithelium in childhood celiac disease. Am. J. Gastroenterol. 99, 894-904 (2004). (Pubitemid 39090220)
83. Tjellstrom, B. et al. Gut microflora associated characteristics in children with celiac disease. Am. J. Gastroenterol. 100, 2784-2788 (2005).
84. Sanz, Y. et al. Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol. Med. Microbiol. 51, 562-568 (2007). (Pubitemid 350076169)
85. Di Cagno, R. et al. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 11, 219 (2011).
86. Nistal, E. et al. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. Inflamm. Bowel Dis. 18, 649-656 (2012).
87. De Palma, G. et al. Intestinal dysbiosis and reduced immunoglobulin- coated bacteria associated with coeliac disease in children. BMC Microbiol. 10, 63 (2010).
88. Collado, M. C., Donat, E., Ribes-Koninckx, C., Calabuig, M. & Sanz, Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J. Clin. Pathol. 62, 264-269 (2009).
89. Nadal, I., Donat, E., Ribes-Koninckx, C., Calabuig, M. & Sanz, Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J. Med. Microbiol. 56, 1669-1674 (2007). (Pubitemid 350276518)
90. Sanchez, E. et al. Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children. BMC Gastroenterol. 8, 50 (2008).
91. Sanchez, E., Ribes-Koninckx, C., Calabuig, M. & Sanz, Y. Intestinal Staphylococcus spp. and virulent features associated with coeliac disease. J. Clin. Pathol. 65, 830-834 (2012).
92. Kagnoff, M. F. et al. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 28, 995-1001 (1987). (Pubitemid 17136879)
93. Benoist, C. & Mathis, D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nature Immunol. 2, 797-801 (2001).
94. Wegner, N. et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and αenolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 62, 2662-2672 (2010).
95. Wu, H. J. et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827 (2010).
96. Saleh, M. & Elson, C. O. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity 34, 293-302 (2011).
97. Khan, K. J. et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am. J. Gastroenterol. 106, 661-673 (2011).
98. Janowitz, H. D., Croen, E. C. & Sachar, D. B. The role of the fecal stream in Crohn's disease: an historical and analytic review. Inflamm. Bowel Dis. 4, 29-39 (1998). (Pubitemid 128699834)
99. Mattner, J. et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host Microbe 3, 304-315 (2008). (Pubitemid 351637431)
100. Shewry, R. P., Tatham, A. & Kasarda, D. D. in Coeliac disease (ed. Marsh, M. N.) (Blackwell Scientific Publications, 1992).
101. Alp, M. H. & Wright, R. Autoantibodies to reticulin in patients with idiopathic steatorrhoea, coeliac disease, and Crohn's disease, and their relation to immunoglobulins and dietary antibodies. Lancet 2, 682-685 (1971).
102. Seah, P. P., Fry, L., Rossiter, M. A., Hoffbrand, A. V. & Holborow, E. J. Anti-reticulin antibodies in childhood coeliac disease. Lancet 2, 681-682 (1971).
103. Chorzelski, T. P. et al. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Br. J. Dermatol. 111, 395-402 (1984). (Pubitemid 14006288)
104. Ladinser, B., Rossipal, E. & Pittschieler, K. Endomysium antibodies in coeliac disease: an improved method. Gut 35, 776-778 (1994). (Pubitemid 24193220)
105. Sanchez, D. et al. Occurrence of IgA and IgG autoantibodies to calreticulin in coeliac disease and various autoimmune diseases. J. Autoimmun. 15, 441-449 (2000).
106. Clemente, M. G. et al. Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study. Am. J. Gastroenterol. 99, 1551-1556 (2004). (Pubitemid 39180106)
107. Rostom, A. et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128, S38-S46 (2005). (Pubitemid 40460820)
108. Husby, S. et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J. Pediatr. Gastroenterol. Nutr. 54, 136-160 (2012).
109. Lorand, L. & Graham, R. M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nature Rev. Mol. Cell. Biol. 4, 140-156 (2003). (Pubitemid 36172696)
110. Piper, J. L., Gray, G. M. & Khosla, C. High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue. Biochemistry 41, 386-393 (2002). (Pubitemid 34049414)
111. Stamnaes, J., Pinkas, D. M., Fleckenstein, B., Khosla, C. & Sollid, L. M. Redox regulation of transglutaminase 2 activity. J. Biol. Chem. 285, 25402-25409 (2010).
112. Dorum, S. et al. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are peptide fragments harboring celiac disease Tcell epitopes. PLoS ONE 5, e14056 (2010).
113. Maslowski, K. M. & Mackay, C. R. Diet, gut microbiota and immune responses. Nature Immunol. 12, 5-9 (2011).